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Fawcett and Meeks: HB 362 & HB 588 - Controlled Substances

CRIMES AND OFFENSES
Controlled Substances: Amend Article 2 of Chapter 13 of Title 16
of the Official Code of Georgia Annotated, Relating to Regulation
of Controlled Substances, so as to Change Provisions Relating to
Possession of Substances Containing Ephedrine, Pseudoephedrine,
and Phenylpropanolamine and Restrictions on Sales of Products
Containing Pseudoephedrine; Provide for Real-Time Tracking of
Sales of Products Containing Ephedrine, Pseudoephedrine;
Provide for Definitions; Revise Provisions Relating to Exceptions;
Provide for Related Matters; Repeal Conflicting Laws; and for
Other Purposes
CODE SECTIONS:
BILL NUMBER:
ACT NUMBER:
GEORGIA LAWS:
SUMMARY:

EFFECTIVE DATE:

O.C.G.A. § 16-13-30.3
HB 362; HB 588
392
2016 Ga Laws 273
The Act mandates the installation of
real-time electronic tracking systems in
all pharmacies that sell products
containing
ephedrine
and
pseudoephedrine, which are ingredients
used
in
the
manufacture
of
methamphetamine. When customers
attempt to purchase more than the
maximum amount of these products,
the tracking system blocks the sale by
issuing a stop sale alert.
July 1, 2016

History
Methamphetamine, also known as “meth” or “crystal meth,” is one
of the most addictive controlled substances.1 Methamphetamine
1. About Methamphetamine, GA.
Info/index.php (last visited Sep. 3, 2016).

METH

PROJECT,

http://georgiamethproject.org/Meth-
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dramatically affects the pleasure centers of the brain, and eventually
leaves user incapable of deriving pleasure from anything other than
the drug, driving abusers further into addiction.2 Other side effects of
the drug include extreme violence, anxiety, insomnia, paranoia,
visual and auditory hallucinations, and delusions.3
While most methamphetamine is manufactured in “superlabs”
across the United States and Mexico, the drug is also easily created in
small, makeshift laboratories using inexpensive over-the-counter
ingredients,
such
as
pseudoephedrine
and
ephedrine.4
Pseudoephedrine and ephedrine are commonly found in cold
medicines.5 In an effort to eliminate these smaller labs, thirty-two
states have armed their pharmacies, supermarkets, and law
enforcement agencies with advanced real-time electronic logging
systems to track the purchase of products containing
pseudoephedrine and ephedrine.6
For the past seven years, the Georgia House of Representatives has
attempted to pass legislation mandating pharmacies and supermarkets
to use electronic tracking systems.7 Though CVS and other big-box
pharmacies in Georgia already use electronic tracking systems, the
high cost of implementation prevents many supermarkets and
independent pharmacies from using these systems.8 Consequently,
many supermarkets and pharmacies in Georgia still use “paper logs
and handwritten entries” to record the purchase of products
containing pseudoephedrine and ephedrine.9
2. What Are the Long-Term Effects of Methamphetamine Abuse?, NAT’L INST. ON DRUG ABUSE,
https://www.drugabuse.gov/publications/research-reports/methamphetamine/what-are-long-termeffects-methamphetamine-abuse (last visited Sep. 3, 2016).
3. Id. A common delusion of abusers is the sensation of insects crawling under the skin. Id.
4. DrugFacts: Methamphetamine, NAT’L INST. ON DRUG ABUSE, https://www.drugabuse.gov/
publications/drugfacts/methamphetamine (last updated Jan. 2014) [hereinafter DrugFacts]; What’s in
Meth, THE METH PROJECT, http://www.methproject.org/answers/what-is-meth.html#Whats-in-Meth
(last visited Sep. 3, 2016) (listing other common ingredients including acetone, lithium, toluene,
hydrochloric acid, red phosphorus, sodium hydroxide, sulfuric acid, and anhydrous ammonia).
5. DrugFacts, supra note 4.
6. Kristina Torres, Georgia House Votes to Enforce Limits for Medicine Used to Make Meth,
ATLANTA J.-CONST. (Feb. 16, 2016, 1:56 PM), http://www.ajc.com/news/news/state-regional-govtpolitics/georgia-house-votes-to-enforce-limits-for-medicine/nqQ67/;
NPLEx
States,
APPRISS,
http://www.appriss.com/nplex.html (last visited Sep. 3, 2016).
7. Telephone Interview with Rep. Valerie Clark (R-101st) (July 8, 2016) [hereinafter Clark
Interview].
8. Id.
9. Laura Diaz, Ga. Bill Would Enforce Limits on Purchases of Medicine Used in Meth, ATLANTA
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During Georgia’s 2016 legislative session, the Georgia House
made its eighth attempt to pass a bill requiring real-time tracking of
products containing pseudoephedrine and ephedrine. 10 The bill,
House Bill (HB) 588—later changed to HB 362—offers the
electronic tracking system free of charge to supermarkets,
pharmacies, and law enforcement agencies across Georgia.11
Bill Tracking of HB 588
Consideration by the House
Representatives Valerie Clark (R-101st), Sharon Cooper (R-43rd),
Bruce Broadrick (R-4th), E. Culver “Rusty” Kidd (I-145th), Ed
Rynders (R-152nd), and Barbara Sims (R-123rd) sponsored HB
588.12 The House read the bill for the first time on March 11, 2015
and recommitted it to the Health and Human Services committee.13
The House Committee on Health and Human Services offered a
substitute to the bill, which the House read on January 27, 2016.14
The Committee substitute reorganized much of the introduced
bill’s substantive inserts.15 For example, the substitute removed the
phrase “retail distributor” and the word “norpsuedoephedrine.”16 The
substitute also significantly changed Section (c) by removing
language that forced retailers to sell products containing only
pseudoephedrine from behind a counter or similar barrier.17
Between March 13, 2015 and January 27, 2016, the Committee
met separately with small pharmacies, grocery store pharmacies, the
GBI, Director Rick Allen from the Georgia Drugs and Narcotics

J.-CONST.: MYAJC (Jan. 29, 2016, 4:28 PM), http://www.myajc.com/news/news/state-regional-govtpolitics/ga-bill-would-enforce-limits-on-purchases-of-medic/nqFqh/.
10. Torres, supra note 6.
11. Diaz, supra note 9.
12. Georgia General Assembly, HB 588, Bill Tracking,
http://www.legis.ga.gov/Legislation/en-US/display/20152016/HB/588.
13. State of Georgia Final Composite Status Sheet, HB 588, May 5, 2016. The House read the bill
again on March 13, 2015. Id.
14. Id.
15. Compare HB 588, as introduced, 2015 Ga. Gen. Assemb., with HB 588 (6327S), 2016 Ga. Gen.
Assemb.
16. Id.
17. HB 588 (6327S), § 1, p. 3, ll. 63–65, 2016 Ga. Gen. Assemb.
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Agency, and Attorney General Sam Olens.18 They all suggested
allowing the information to go the GBI first, instead of the national
database, which would allow these regulations “to be better
enforced.”19 Representative Clark believes Mr. Clark’s and Mr.
Olens’ changes “made a better bill.”20
The Rules Committee withdrew the bill and recommitted it to the
Committee on Health and Human Services on February 4, 2016.21
The new substitute kept all of the changes and phrasing of the
previous substitute, except for a change in subsection (a)(4)(B).22
This section specified retailers would not have to pay transaction fees
for tracking software.23
The House Committee on Health and Human Services favorably
reported the bill on February 10, 2016.24 The House read the bill for
the third time on February 16, 2016.25 It passed the same day by a
vote of 151 to 19.26
Consideration by the Senate
Senator Renee Unterman (R-45th) sponsored HB 588 in the
Senate.27 The Senate first read HB 588 on February 17, 2016, and
assigned it to the Senate Health and Human Services Committee.28
The Senate Health and Human Services Committee favorably
reported the bill on March 7, 2016.29 The Senate read the bill for the
second time on March 8, 2016.30

18. Clark Interview, at 7:40–9:18
19. Id.
20. Id.
21. State of Georgia Final Composite Status Sheet, HB 588, May 5, 2016.
22. Compare HB 588 (6327S), § 1, p. 2, l. 41, 2016 Ga. Gen. Assemb., with HB (6465S), § 1, p. 2, l.
41, 2016 Ga. Gen. Assemb.
23. HB 588 (6465S), § 1, p. 2, l. 4l, 2016 Ga. Gen. Assemb.
24. State of Georgia Final Composite Status Sheet, HB 588, May 5, 2016.
25. Id.
26. Georgia House of Representatives Voting Record, HB 588, Vote #542 (Feb. 16, 2016).
27. Georgia General Assembly, HB 588, Bill Tracking,
http://www.legis.ga.gov/legislation/en-US/Display/20152016/HB/588.
28. State of Georgia Final Composite Status Sheet, HB 588, May 5, 2016.
29. Id.
30. Id.
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On March 15, 2016, the Senate read HB 588 for the third time.31
After the third reading, Senators Unterman (R-45th), Rick Jeffares
(R-17th), Bill Jackson (R-24th), and Chuck Hufstetler (R-52nd)
proposed a floor amendment to the bill.32 The amendment
recommended revising paragraph (e.1)(1) and adding subparagraph
(e.1)(1)(B) to Code section 43-34-103.33 The recommended revisions
would allow physician assistants to write prescription drug orders for
hydrocodone compounds.34 Physician assistants had lost the power to
prescribe such drugs in 2014 when the Drug Enforcement Agency
(DEA) moved several Schedule III drugs, such as hydrocodone based
compounds, up to Schedule II.35
The Senate adopted the amendment by a vote of 22 to 3.36 It then
passed HB 588 as amended on March 15, 2016, by a vote of 39 to
1.37 The bill was then set aside to be resolved in a conference
committee with the House.38
Reconsideration of HB 588 by the House and its Transformation
into HB 362
The Chairwoman of Health and Human Services, Representative
Cooper, and other members of the House took issue with the Senate’s
amendments to HB 588, granting physician assistants the ability to
prescribe Schedule II drugs.39 Representative Cooper and others
expressed serious concern that the amendment would ease access to
highly addictive drugs, thereby furthering opioid abuse in Georgia.40
Opponents of the Senate amendments fears are bolstered by statistics
showing that prescription drug abuse in Georgia has declined since
31. Id.
32. Video Recording of Senate Proceedings, Mar. 15, 2016 at 5 min., 5 sec. (remarks by Sen.
Jeffares (R-17th)), http://www.gpb.org/lawmakers/2016/day-37 [hereinafter Senate Video].
33. HB 588 (SFA), p. 1, l. 8, 2016 Ga. Gen. Assemb.
34. Senate Video, supra note 32, at 5 min., 5 sec. (remarks by Sen. Jeffares (R-17th)).
35. Diane Wagner, Sen. Chuck Hufstetler at Work on Health Bills for Action in January, ROME
NEWS-TRIB. (Nov. 30, 2015, 9:00 AM), http://www.northwestgeorgianews.com/rome/news/local/senchuck-hufstetler-at-work-on-health-bills-for-action/article_f4c37316-973f-11e5-a7e78b72936e0914.html.
36. Senate Video, supra note 32, at 5 min., 53 sec. (remarks by LG Casey Cagle).
37. Georgia Senate Voting Record, HB 588, Vote #604 (Mar. 15, 2016).
38. Senate Video, supra note 32, at 5 min., 25 sec. (remarks by Sen. Unterman (R-45th)).
39. Clark Interview, supra note 7, at 4 min., 10 sec.
40. Id.
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the DEA moved hydrocodone compounds and other Schedule II
drugs above the prescription authority of physician assistants.41
Even though the House and Senate remained in agreement about
the importance of HB 588’s initial purpose—installing electronic
tracking systems in drug stores to track the sale of
pseudoephedrine—the House refused to pass the bill as amended.42
As a solution, the House and Senate decided to proceed without the
amendment and added HB 588 to HB 362.43 Both the House and the
Senate passed HB 362 on March 24, 2016.44
The Act (HB 362)
The Act creates Code section 16-13-30.3 of Article 2 of Chapter
13 of Title 16.45 This section defines several different terms related to
the electronic tracking system, outlines the requirements of the
tracking system, and sets out the punishment for anyone in violation
of the code section.46 Code section 16-13-30.3(a)(1) defines
ephedrine and pseudoephedrine as “any drug product containing
ephedrine or pseudoephedrine, or any other of their salts, isomers, or
salts of isomers, alone or in a mixture.”47
Real-Time Tracking System
Code section 16-13-30.3 mandates all pharmacies to install
electronic logging systems that operate in real time and generate stop
sale alerts to notify pharmacists when someone has purchased more
than the maximum amount of ephedrine or pseudoephedrine.48 To
ensure pharmacist safety, however, every system must also be
equipped with a safety override. The safety override function allows
pharmacists to complete a sale in violation of Code section

41.
42.
43.
44.
45.
46.
47.
48.

Id. at 5 min., 5 sec.
Id.
Id.
State of Georgia Final Composite Status Sheet, HB 362, May 5, 2016.
O.C.G.A. § 16-13-30.3 (Supp. 2016).
Id.
O.C.G.A. § 16-13-30.3(a)(1).
O.C.G.A. § 16-13-30.3(a)(4), (c)(4)(A).
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16-13-30.3 when he or she is in reasonable fear of imminent bodily
harm as a consequence of not completing the sale.49
When an individual buys any product containing ephedrine or
pseudoephedrine for the first time, he or she is required to give the
pharmacist his or her full name, address, and present a government
issued identification card.50 The pharmacist must input this
information into the tracking system, along with a description of the
nonprescription ephedrine or pseudoephedrine product, including the
number of grams of ephedrine or pseudoephedrine contained in the
product, and the time and date of purchase.51 The pharmacy must
keep records of all sales for a period of two years from the date of
each transaction.52 The records are accessible to Georgia law
enforcement agencies through an online portal maintained by the
Georgia Bureau of Investigation.53
Every logging system must be approved by the Georgia Bureau of
Investigation and must be accessible to the state, pharmacies, and law
enforcement completely free of charge.54
While such systems must have real-time interstate
communicability with similar systems in other states, the records
maintained by a pharmacy shall not be disclosed to anyone other than
Georgia law enforcement agencies.55
Criminalizing Possession of Products Containing Ephedrine or
Pseudoephedrine
Code section 16-13-30.3 (b)(1) states that any person who possess
more than 300 pills, tablets, gelcaps, or capsules that contain
ephedrine or pseudoephedrine or more than nine grams of ephedrine
shall be guilty of a felony punishable by imprisonment for not less
than one year but no more than ten.56 The same punishment applies
to someone who possesses any amount of ephedrine- or
49.
50.
51.
52.
53.
54.
55.
56.
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O.C.G.A. § 16-13-30.3(a)(4).
O.C.G.A. § 16-13-30.3(a)(5), (c)(3).
O.C.G.A. § 16-13-30.3(a)(5), (c)(3).
O.C.G.A. § 16-13-30.3(c)(3).
O.C.G.A. § 16-13-30.3(c)(4)(D).
O.C.G.A. § 16-13-30.3(a)(4).
O.C.G.A. § 16-13-30.3(c)(3).
O.C.G.A. § 16-13-30.3(b)(1), (3).
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pseudoephedrine-based products with the intent to manufacture
amphetamine or methamphetamine, or anyone who possesses, with
the intent to distribute, any product containing any amounts of
ephedrine or pseudoephedrine that have been crushed, powdered,
liquefied, or altered in any other manner.57 A person may legally
purchase or sell 3.6 grams of ephedrine or pseudoephedrine per
day.58 However, this amount cannot reach more than nine grams per
thirty-day period.59
Products Containing Pure Ephedrine or Pseudoephedrine
Code section 16-13-30.3(c)(1) states that any products whose sole
active ingredient is pseudoephedrine must be sold in blister
packaging.60 Any nonprescription products whose sole active
ingredient is ephedrine or pseudoephedrine must comply with Code
section 16-13-29.2.61
Liability of Pharmacies
Starting January 1, 2017, pharmacies that do not use a real time
tracking system will not be permitted to sell products containing
ephedrine or pseudoephedrine.62 If, for some reason, the system
malfunctions, the pharmacy must record any sales in either a written
or an electronic log.63 Pharmacies are also prohibited from selling
any non-prescription product that contains more than 3.6 grams of
ephedrine or pseudoephedrine per day dosage or more than 9 grams
per a 30 day period dosage to an individual.64 And as noted above, if
the sole active ingredient is pseudoephedrine it must be sold in blister
packaging.65 Any pharmacy or pharmacist who fails to comply with
any of the above requirements or fails to record sales shall be guilty
57.
58.
59.
60.
61.
62.
63.
64.
65.

O.C.G.A. § 16-13-30.3(b)(2), (e).
O.C.G.A. § 16-13-30.3(c)(2).
Id.
O.C.G.A. § 16-13-30.3(c)(1).
Id.
O.C.G.A. § 16-13-30.3(c)(4).
O.C.G.A. § 16-13-30.3(c)(4)(B).
O.C.G.A. § 16-13-30.3(c)(1), (2).
O.C.G.A. § 16-13-30.3(c)(1).
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of a misdemeanor punishable of a fine no more than $500 upon first
conviction and upon second conviction no more than six months
imprisonment, a $1000 fine, or both.66
If a pharmacy buys products containing ephedrine or
pseudoephedrine from anyone other than a manufacturer or
distributor licensed by the State Board of Pharmacy, it shall be guilty
of a misdemeanor and upon the second conviction shall be guilty of a
high and aggravated misdemeanor.67
It shall be a defense to any of the above criminal allegations, if all
employees of the pharmacy completed training that complied with
the standards established by Georgia Meth Watch as of June 30,
2016, and the pharmacy actually complied with the procedures
developed by Georgia Meth Watch.68 Except in cases of negligence,
wantonness, recklessness, or deliberate misconduct, pharmacies
using the real-time tracking system cannot be held civilly liable for
any act or omission in carrying out the duties required by Code
section 16-13-30.3.69 Pharmacies are also immune from liability to
any third party unless the pharmacy violates Code section
16-13-30.3.70
Analysis
Comparison With Other States
By adopting HB 362, Georgia joins the several other states that
have passed legislation requiring drug tracking programs.71 In
particular, Georgia’s neighboring states have adopted such legislation
because the drug tracking system leads investigators “to meth labs
[they] otherwise wouldn’t know about.”72 Mississippi is the only
other state in the southeast that has not implemented a requirement
66. O.C.G.A. § 16-13-30.3(c)(7)(A).
67. O.C.G.A. § 16-13-30.3(c)(7)(B).
68. O.C.G.A. § 16-13-30.3(c)(7)(C).
69. O.C.G.A. § 16-13-30.3(c)(4)(C).
70. Id.
71. Torres, supra note 6; see NPLEx States, APPRISS (2015), http://www.appriss.com/nplex.html
(last visited Sep. 3, 2016).
72. Press Release, N.C. Dep’t of Just., Technology leads to record number of meth lab busts in NC
(Jan. 19. 2014), http://www.ncdoj.gov/News-and-Alerts/News-Releases-and-Advisories/Press-Releases/
Technology-leads-to-record-number-of-meth-lab-bust.aspx.
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for pharmacies to join a real-time electronic logging system.73 With
the passage of HB 588, Georgia has joined the majority of its
neighbors in taking steps to curb meth production.
Intended Consequences
At its core, this law aims to further restrict methamphetamine
makers’ ability to obtain the necessary supplies.74 Yet, the law also
allows consumers to more easily obtain allergy medications by taking
them to the shelves instead of placing them behind pharmacy
counters.75 To combat the concern that this would create an easier
avenue for methamphetamine producers to gather the requisite
ingredients, the Act requires all pharmacies to have a real-time
electronic logging system.76
First, this Act prevents methamphetamine producers from taking
advantage of small pharmacies by going to multiple pharmacies in a
single day and purchasing more than the maximum amount of the
drugs.77 Without a real-time system to inform a pharmacy that a
purchaser recently bought the same drug somewhere else, purchasers
were able to get around the legal limit.78 This Act prevents that from
occurring because of its real-time logging component.79 The realtime technology allows pharmacies to track the amount of a drug
purchased by an individual at any pharmacy in the state.80
Mild Opposition
The Act initially had some opposition.81 The most notable concern
dealt with the vesting of power in physician assistant’s to prescribe
73. See NPLEx, supra note 6.
74. Torres, Kristina, Georgia Senate Backs Bill Limiting Medicine Used to Make Meth, ATLANTA J.CONST. (Mar. 15, 2016 1:41 PM), http://www.ajc.com/news/news/state-regional-govt-politics/georgiasenate-backs-bill-limiting-medicine-used-t/nqk4J/.
75. Diaz, supra note 9.
76. Id.
77. FINAL REPORT OF THE SENATE STUDY COMMITTEE ON THE CREATION OF A GEORGIA
METHCHECK DATABASE, S. 150, Reg. Sess., at 8 (2009).
78. Id. at 6.
79. O.C.G.A. § 16-13-30.3(c)(4)(A) (Supp. 2016).
80. See Diaz, supra note 9.
81. Georgia House Voting Record, HB 588, Vote #542 (Feb. 16, 2016) (passing the House by a vote
of 151-19); Georgia Senate Voting Record, HB 588, Vote #604 (Mar. 15, 2016) (passing the Senate by a
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painkillers.82 However, support from the GBI, attorney general, and
director of the Georgia Drugs and Narcotics Agency in favor of the
tracking implementation apparently outweighed the detractors’
original concerns.83 The bill also directly addressed any potential
opposition—although none materialized—from pharmacies, who
could have been concerned about liability in situations out of their
control, such as system outages, by carving out protections for
pharmacies that attempt to comply with the system.84 Further, the
pharmaceutical companies that backed the Act offered to pay for the
logging system.85 Thus, pharmacies that might fear increased costs
will incur no extra expense from implementation of the real-time
monitoring system.86
This Act does not hurt pharmacies, because it does not require
them to pay for the monitoring expense.87 At the same time, this Act
will make it more difficult for meth producers to acquire the
necessary supplies, because it requires every pharmacy to utilize the
real-time tracking system.88 Other states that have adopted the system
have seen a substantial increase in the amount of blocked sales of
pseudoephedrine.89 For example, Arkansas began using the tracking
system in 2015, and within the first year blocked 3,873 sales of
banned ingredients; from January through June of 2016, Arkansas
blocked 3,722 sales.90 North Carolina found the system helped in
setting a record for meth lab busts.91 Finally, the Act makes it easier
for consumers to obtain necessary allergy medications by moving
these medications from behind the counter back onto the shelves.92
William Fawcett & April Meeks
vote of 39-1); Clark Interview supra note 7, at 9:15.
82. Id.
83. Id.
84. O.C.G.A. § 16-13-30.3(c)(4) (Supp. 2016).
85. Torres, supra note 74.
86. Id.
87. Id.
88. O.C.G.A. § 16-13-30.3(a)(4), (c)(4)(A) (Supp. 2016).
89. See generally Appriss tables, infra note 91.
90. Compare Appriss 2015 year end table (http://www.appriss.com/actionable/NPLEx/
EOY2015.htm), with Apriss 2016 2Q table (http://www.appriss.com/actionable/NPLEx/
2Q2016Stats.htm).
91. N.C. Dep’t Just., supra note 72.
92. See Diaz, supra note 9.
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